Efficacy of the oral nucleoside prodrug GS-5245 (Obeldesivir) against SARS-CoV-2 and coronaviruses with pandemic potential https://www.biorxiv.org/content/10.1101/2023.06.27.546784v1?med=mas
Efficacy of the oral nucleoside prodrug GS-5245 (Obeldesivir) against SARS-CoV-2 and coronaviruses with pandemic potential https://www.biorxiv.org/content/10.1101/2023.06.27.546784v1?med=mas